Renal Dose Meropenem
For adult patients with renal impairment, meropenem dosing must be adjusted based on creatinine clearance: use the full recommended dose (500 mg or 1 g depending on infection type) every 12 hours for CrCl 26-50 mL/min, half the recommended dose every 12 hours for CrCl 10-25 mL/min, and half the recommended dose every 24 hours for CrCl <10 mL/min. 1
Dosing Algorithm by Renal Function
Normal Renal Function (CrCl >50 mL/min)
- Complicated skin/skin structure infections: 500 mg IV every 8 hours
- Pseudomonas aeruginosa infections: 1 g IV every 8 hours
- Complicated intra-abdominal infections: 1 g IV every 8 hours
- Administer as 15-30 minute infusion or 3-5 minute bolus 1
Moderate Renal Impairment (CrCl 26-50 mL/min)
- Use the full recommended dose (500 mg for cSSSI, 1 g for intra-abdominal)
- Extend interval to every 12 hours 1
Severe Renal Impairment (CrCl 10-25 mL/min)
- Use half the recommended dose (250 mg for cSSSI, 500 mg for intra-abdominal)
- Administer every 12 hours 1
Very Severe Renal Impairment (CrCl <10 mL/min)
- Use half the recommended dose (250 mg for cSSSI, 500 mg for intra-abdominal)
- Administer every 24 hours 1
Critical Considerations
Hemodialysis patients: The FDA label states there is inadequate information for specific dosing recommendations in patients on hemodialysis or peritoneal dialysis 1. However, recent research suggests that for patients on continuous renal replacement therapy (CRRT), meropenem clearance increases approximately 2.1-fold compared to non-CRRT patients with renal impairment, requiring higher doses (0.5 g every 6 hours as 3-hour infusion) 2.
Augmented renal clearance (ARC): Critically ill patients with CrCl >130 mL/min demonstrate significantly reduced target attainment 3, 4, 5. For these patients, consider intensified regimens such as 1 g every 8 hours as prolonged (3-8 hour) infusions to achieve pharmacodynamic targets 3, 4.
Calculating Creatinine Clearance
Use the Cockcroft-Gault equation when only serum creatinine is available 1:
Males: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
Females: 0.85 × above value
Infusion Strategy Optimization
Prolonged infusions (3 hours) significantly improve target attainment compared to standard 0.5-hour infusions across all renal function categories 4. At MIC values up to 8 mg/L, 3-hour infusions achieved 96% probability of target attainment (40% fT>MIC) for 2 g every 8 hours in patients with CrCl ≥50 mL/min, compared to only 75% with standard infusions 4.
Common Pitfalls
- Do not use probenecid concurrently—it inhibits renal excretion of meropenem and is not recommended 1
- Avoid underdosing in CRRT: Standard renal impairment dosing is insufficient for patients on continuous renal replacement therapy 2
- Monitor for seizures: Risk increases with renal dysfunction, particularly when doses are not appropriately reduced 1
- Reassess with changing renal function: Critically ill patients often have dynamic renal function requiring dose adjustments 3, 6